Halozyme Therapeutics, Inc. (LON:0J2O)
London · Delayed Price · Currency is GBP · Price in USD 76.32
-0.71 (-0.92%)
At close: Sep 15, 2025
Halozyme Therapeutics Employees
Halozyme Therapeutics had 350 employees as of December 31, 2024. The number of employees decreased by 23 or -6.17% compared to the previous year.
Employees
350
Change (1Y)
-23
Growth (1Y)
-6.17%
Revenue / Employee
2.46M GBP
Profits / Employee
1.16M GBP
Market Cap
6.49B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 350 | -23 | -6.17% |
| Dec 31, 2023 | 373 | -20 | -5.09% |
| Dec 31, 2022 | 393 | 248 | 171.03% |
| Dec 31, 2021 | 145 | 9 | 6.62% |
| Dec 31, 2020 | 136 | 4 | 3.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,500 |
Halozyme Therapeutics News
- 9 days ago - Halozyme Therapeutics, Inc. (HALO) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 13 days ago - Halozyme Therapeutics, Inc. (HALO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Prepared Remarks Transcript - Seeking Alpha
- 15 days ago - Insider Sell: Bernadette Connaughton Sells 4,000 Shares of Halozyme Therapeutics Inc (HALO) - GuruFocus
- 19 days ago - Identify Superstar Stocks Like Halozyme with Money Flows - FX Empire
- 20 days ago - Halozyme to Participate at Upcoming Investor Conferences - PRNewsWire
- 5 weeks ago - What Does the Market Think About Halozyme Therapeutics? - Benzinga
- 6 weeks ago - Halozyme up after guidance raise, Morgan Stanley upgrade - Seeking Alpha
- 6 weeks ago - Halozyme raises 2025 revenue guidance to $1.355B amid accelerating royalty growth and new product catalysts - Seeking Alpha